BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9853989)

  • 1. Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay.
    Beal JL; Jones CE; Taylor PJ; Tett SE
    Ther Drug Monit; 1998 Dec; 20(6):685-90. PubMed ID: 9853989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytic validation of the enzyme multiplied immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay.
    Hosotsubo H; Takahara S; Imamura R; Kyakuno M; Tanaka T; Yazawa K; Hanafusa T; Matsumiya K; Nonomura N; Okuyama A; Sugimoto H
    Ther Drug Monit; 2001 Dec; 23(6):669-74. PubMed ID: 11802102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy.
    Weber LT; Shipkova M; Armstrong VW; Wagner N; Schütz E; Mehls O; Zimmerhackl LB; Oellerich M; Tönshoff B
    Clin Chem; 2002 Mar; 48(3):517-25. PubMed ID: 11861442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the EMIT Mycophenolic Acid Assay from Dade Behring.
    Vogl M; Weigel G; Seebacher G; Griesmacher A; Laufer G; Müller MM
    Ther Drug Monit; 1999 Dec; 21(6):638-43. PubMed ID: 10604825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients.
    Kunicki PK; Pawiński T; Boczek A; Waś J; Bodnar-Broniarczyk M
    Ther Drug Monit; 2015 Jun; 37(3):311-8. PubMed ID: 25380305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring.
    Prémaud A; Rousseau A; Le Meur Y; Lachâtre G; Marquet P
    Ther Drug Monit; 2004 Dec; 26(6):609-19. PubMed ID: 15570184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit.
    Shipkova M; Schütz E; Armstrong VW; Niedmann PD; Oellerich M; Wieland E
    Clin Chem; 2000 Mar; 46(3):365-72. PubMed ID: 10702523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry.
    Prémaud A; Rousseau A; Picard N; Marquet P
    Ther Drug Monit; 2006 Apr; 28(2):274-7. PubMed ID: 16628144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation into the bias between liquid chromatography-tandem mass spectrometry and an enzyme multiplied immunoassay technique for the measurement of mycophenolic acid.
    Brown NW; Franklin ME; Einarsdottir EN; Gonde CE; Pires M; Taylor PJ; Tredger JM
    Ther Drug Monit; 2010 Aug; 32(4):420-6. PubMed ID: 20592649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients.
    Irtan S; Azougagh S; Monchaud C; Popon M; Baudouin V; Jacqz-Aigrain E
    Pediatr Nephrol; 2008 Oct; 23(10):1859-65. PubMed ID: 18594872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
    Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E
    Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of high-performance liquid chromatography and enzyme multiplied immunoassay technology methods for determination of free mycophenolic acid and its application in Chinese liver transplant recipients.
    Chen B; Gu Z; Chen H; Zhang W; Fen X; Cai W; Fan Q
    Ther Drug Monit; 2010 Oct; 32(5):653-60. PubMed ID: 20814351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the EMIT immunoassay for the measurement of unbound mycophenolic acid in plasma.
    Rebollo N; Calvo MV; Martín-Suárez A; Domínguez-Gil A
    Clin Biochem; 2011 Feb; 44(2-3):260-3. PubMed ID: 20923675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of mycophenolic acid monitoring by an enzyme multiplied immunoassay technique.
    Martiny D; Macours P; Cotton F; Thiry P; Gulbis B
    Clin Lab; 2010; 56(7-8):345-53. PubMed ID: 20857899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma.
    Westley IS; Sallustio BC; Morris RG
    Clin Biochem; 2005 Sep; 38(9):824-9. PubMed ID: 15963486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolic acid monitoring in HTX patients: a preliminary report.
    Müller MM; Vogl M; Griesmacher A
    Therapie; 1997; 52(4):341-4. PubMed ID: 9437889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
    Weber LT; Lamersdorf T; Shipkova M; Niedmann PD; Wiesel M; Zimmerhackl LB; Staskewitz A; Schütz E; Mehls O; Oellerich M; Armstrong VW; Tönshoff B
    Ther Drug Monit; 1999 Oct; 21(5):498-506. PubMed ID: 10519445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EMIT Cyclosporine Assay: development of application protocols for the Boehringer Mannheim Hitachi 911 and 917 analyzers.
    Dias VC; Legatt DF; Yatscoff RW
    Clin Biochem; 1997 Mar; 30(2):155-62. PubMed ID: 9127698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical validation of a homogeneous immunoassay for determination of mycophenolic acid in human plasma.
    Vergara Chozas JM; Sáez-Benito Godino A; Zopeque García N; García Pinteño S; Joumady I; Carrasco García C; Vara Gil F
    Transplant Proc; 2012 Nov; 44(9):2669-72. PubMed ID: 23146489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.